S
FLNA

SignatureFD’s Filana Therapeutics FLNA Stock Holding History

SignatureFD’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-54
Closed -$1.59K – 3387
2024
Q3 		$1.59K Buy
+54
New +$1.24K ﹤0.01% 2889
2024
Q2 		– Sell
-54
Closed -$1.1K – 3239
2024
Q1 		$1.1K Buy
54
+11
+26% +$253 ﹤0.01% 2934
2023
Q4 		$968 Sell
43
-37
-46% -$782 ﹤0.01% 2908
2023
Q3 		$1.33K Buy
80
+36
+82% +$713 ﹤0.01% 2880
2023
Q2 		$1.08K Sell
44
-3
-6% -$72 ﹤0.01% 2955
2023
Q1 		$1.13K Sell
47
-74
-61% -$2.05K ﹤0.01% 2954
2022
Q4 		$3.57K Sell
121
-24
-17% -$863 ﹤0.01% 2604
2022
Q3 		$6K Buy
145
+73
+101% +$1.97K ﹤0.01% 2373
2022
Q2 		$2K Sell
72
-256
-78% -$6.46K ﹤0.01% 2796
2022
Q1 		$12K Hold
328
– – ﹤0.01% 2085
2021
Q4 		$14K Sell
328
-600
-65% -$31.5K ﹤0.01% 1956
2021
Q3 		$58K Buy
928
+550
+146% +$45.9K ﹤0.01% 1239
2021
Q2 		$32K Buy
378
+28
+8% +$1.5K ﹤0.01% 1510
2021
Q1 		$16K Buy
+350
New +$13.8K ﹤0.01% 1665

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

SignatureFD's FLNA Position: Q4 2024 in Review

SignatureFD sold out of Filana Therapeutics (FLNA) in Q4 2024, closing a stake of 54 shares — an estimated $1.59K sold.

SignatureFD first reported a position in FLNA in Q1 2021 and held it in 14 quarters. The position peaked at $58K in Q3 2021. 137 funds tracked by Wall St. Rank hold FLNA as of Q4 2024.

  • SignatureFD reported no remaining Filana Therapeutics position as of Q4 2024 after selling out during the quarter.
  • SignatureFD sold 54 Filana Therapeutics shares in Q4 2024, an estimated $1.59K.
  • SignatureFD first reported a position in Filana Therapeutics in Q1 2021 and held it in 14 quarters.
  • SignatureFD's Filana Therapeutics position peaked at $58K in Q3 2021.
  • 137 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2024.

Based on SignatureFD's 13F filing for Q4 2024, filed 10 Feb 2025.